Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard R Watkins

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Review of Anti-Infective Therapy|July 20, 2018
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapiesRichard R Watkins
Infection|January 17, 2026
Contaminating the evidence: the reproducibility crisis and fraud in infectious disease researchRichard R Watkins
Expert Review of Anti-Infective Therapy|September 5, 2012
Investigating the association between vitamin D deficiency and sepsis: challenges and future prospectsRichard R Watkins
Current Infectious Disease Reports|November 26, 2011
Gastrointestinal infections in the setting of natural disastersRichard R Watkins
Jac-Antimicrobial Resistance|June 23, 2022
Antibiotic stewardship in the era of precision medicineRichard R Watkins
Advances in Therapy|May 21, 2022
Using Precision Medicine for the Diagnosis and Treatment of Viral PneumoniaRichard R Watkins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?Richard R Watkins, Stan Deresinski
Expert Review of Anti-Infective Therapy|February 26, 2015
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?Richard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous FormulationsRichard R Watkins, Stan Deresinski
Expert Review of Anti-Infective Therapy|September 16, 2017
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant EnterobacteriaceaeRichard R Watkins, Stan Deresinski
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Anti-Infective Therapy|July 20, 2018
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapiesRichard R Watkins
Infection|January 17, 2026
Contaminating the evidence: the reproducibility crisis and fraud in infectious disease researchRichard R Watkins
Expert Review of Anti-Infective Therapy|September 5, 2012
Investigating the association between vitamin D deficiency and sepsis: challenges and future prospectsRichard R Watkins
Current Infectious Disease Reports|November 26, 2011
Gastrointestinal infections in the setting of natural disastersRichard R Watkins
Jac-Antimicrobial Resistance|June 23, 2022
Antibiotic stewardship in the era of precision medicineRichard R Watkins
Advances in Therapy|May 21, 2022
Using Precision Medicine for the Diagnosis and Treatment of Viral PneumoniaRichard R Watkins
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?Richard R Watkins, Stan Deresinski
Expert Review of Anti-Infective Therapy|February 26, 2015
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?Richard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous FormulationsRichard R Watkins, Stan Deresinski
Expert Review of Anti-Infective Therapy|September 16, 2017
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant EnterobacteriaceaeRichard R Watkins, Stan Deresinski
Pageof 8